Psoriasis Trials in Birmingham, United States
Conditions / Psoriasis / Birmingham, United States
Clinical trials for Psoriasis investigate a range of treatment strategies and patient populations.
56 total trials for this combination
Showing top 10 of 56 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT04036435 | Long-Term Study That Measures the Safety and Efficacy of Deucravacitinib (BMS-986165) in Participants With Psoriasis | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT06846541 | Long-term Safety and Efficacy of ESK-001 in Moderate to Severe Plaque Psoriasis | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT06588283 | Ixekizumab Concomitantly Administered With Tirzepatide in Adults With Moderate-to-Severe Plaque Psoriasis and Obesity or Overweight | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT03816345 | Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO | RECRUITING | — |
| NCT00261976 | A Long-term Safety Study of Infliximab (Remicade) | COMPLETED | — |
| NCT00508547 | Psoriasis Longitudinal Assessment and Registry | ACTIVE_NOT_RECRUITING | — |
| NCT03611751 | An Investigational Study to Evaluate Experimental Medication BMS-986165 Compared to Placebo and a Currently Available Treatment in Participants With Moderate-to-Severe Plaque Psoriasis | COMPLETED | PHASE3 |
| NCT01163253 | A Long Term Study To Evaluate The Safety And Tolerability Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque Psoriasis | TERMINATED | PHASE3 |
| NCT03047395 | A Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis ( LIMMITLESS ) | COMPLETED | PHASE3 |
| NCT02538341 | Safety and Effectiveness of Live Zoster Vaccine in Anti-Tumor Necrosis Factor (TNF) Users (VERVE Trial) | COMPLETED | PHASE2 |